PNPLA2 Gene Neutral Lipid Storage Disease with Myopathy Genetic Test sale cost 4400 AED
BRAT1 Gene Neurodevelopmental Disorder with Cerebellar Atrophy and with or Without Seizures Genetic Test sale cost 4400 AED BRAT1 Gene Neurodevelopmental Disorder with Cerebellar Atrophy and with or Without Seizures Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
FBXO7 Gene PARK15 Parkinson Genetic Test sale cost 4400 AED FBXO7 Gene PARK15 Parkinson Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

PNPLA2 Gene Neutral Lipid Storage Disease with Myopathy Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PNPLA2 Gene Neutral Lipid Storage Disease with Myopathy Genetic Test is a specialized diagnostic assessment performed to identify mutations in the PNPLA2 gene, which are responsible for causing Neutral Lipid Storage Disease with Myopathy (NLSDM). This rare genetic disorder is characterized by the accumulation of neutral lipids in the body’s cells, leading to a variety of symptoms including muscle weakness, cardiomyopathy, and liver dysfunction. The test is crucial for confirming the diagnosis, understanding the disease’s progression, and guiding treatment decisions.

Conducted at DNA Labs UAE, a leading facility in genetic testing, this test offers a comprehensive analysis of the PNPLA2 gene. By examining the specific genetic makeup of an individual, healthcare providers can identify mutations that lead to NLSDM, offering insights into the severity of the condition and potential therapeutic approaches.

The cost of the PNPLA2 Gene Neutral Lipid Storage Disease with Myopathy Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the intricate process of genetic analysis, the expertise required to interpret the results accurately, and the significant value it provides in managing the condition effectively. Patients seeking this test can expect a reliable service that employs advanced genetic testing technologies to deliver precise and actionable findings.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PNPLA2 Gene Neutral lipid storage disease with myopathy Genetic Test

Components: Price – 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PNPLA2 Gene Neutral lipid storage disease with myopathy NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PNPLA2 Gene Neutral lipid storage disease with myopathy.

Test Details

The PNPLA2 gene is associated with neutral lipid storage disease with myopathy, also known as NLSDM. This condition is a rare genetic disorder characterized by the abnormal accumulation of neutral lipids in various tissues, particularly in muscle cells.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of NLSDM, NGS genetic testing can identify mutations or variations in the PNPLA2 gene that may be responsible for the development of the disease.

By analyzing the PNPLA2 gene, NGS genetic testing can help confirm a diagnosis of NLSDM and provide information about the specific genetic variant involved. This information is important for understanding the underlying cause of the disease, predicting its progression, and guiding treatment decisions.

It’s important to note that genetic testing should be performed and interpreted by a qualified healthcare professional or genetic counselor who can provide appropriate counseling and support.

Test Name PNPLA2 Gene Neutral lipid storage disease with myopathy Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PNPLA2 Gene Neutral lipid storage disease with myopathy NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PNPLA2 Gene Neutral lipid storage disease with myopathy
Test Details

The PNPLA2 gene is associated with neutral lipid storage disease with myopathy, also known as NLSDM. This condition is a rare genetic disorder characterized by the abnormal accumulation of neutral lipids in various tissues, particularly in muscle cells.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of NLSDM, NGS genetic testing can identify mutations or variations in the PNPLA2 gene that may be responsible for the development of the disease.

By analyzing the PNPLA2 gene, NGS genetic testing can help confirm a diagnosis of NLSDM and provide information about the specific genetic variant involved. This information is important for understanding the underlying cause of the disease, predicting its progression, and guiding treatment decisions.

It’s important to note that genetic testing should be performed and interpreted by a qualified healthcare professional or genetic counselor who can provide appropriate counseling and support.

SKU: TEST-1869 Category:

Related products